Perceived versus real risks of handling gene transfer agents in the pharmacy environment

May 2010
American Journal of Health-System Pharmacy;5/15/2010, Vol. 67 Issue 10, p838
Academic Journal
The article offers information on the increasing use of gene transfering trials. It reports that gene transfer is currently not approved as a medical therapy by U.S. Food and Drug Administration (FDA). It discusses the risks of handling gene transfer agents in genetic engineering. It provides information about gene transfer agents and recommendations concerning their manipulation.


Related Articles

  • General Mills Investors Reject Proposal Demanding Company Remove GM Ingredients from Products.  // Corn & Soybean Digest Exclusive Insight;9/25/2014, p1 

    The article offers information on the rejection made by the investors of General Mills, manufacturer of consumer food, FOR removing the genetically-modified organisms (GMOs) from its products. It mentions the views of Justin Danhof, National Center Free Enterprise Project Director on the risk of...

  • No longer science fiction….  // Choice;Apr2007, p12 

    The article reports on the release of a draft risk assessment of the safety of food derived from clone animals by the U.S. Food and Drug Administration. The report concluded that, scientifically, clones should be identical to the parent. Food Standards Australia New Zealand (FSANZ) is continuing...

  • Is it or isn't it? Edwards, Rob // New Scientist;03/04/2000, Vol. 165 Issue 2228, p5 

    Reports on the presence of conflicting evidence used to determine the safety of genetically modified (GM) foods. Concern caused by the damage to the immune systems of rats who were fed genetically engineered potatoes; Research performed by Zhang-Liang Chen of Beijing University indicating no...

  • Caveat Emptor. Mulvey, Therese M. // Journal of Oncology Practice;May2010, Vol. 6 Issue 3, p169 

    In this article, the author discusses on the updated guideline of American Society of Clinical Oncology (ASCO) for genetic risk assessment and genetic testing. It says that the guideline calls for increased physician education on genomic testing and regulation of tests by U.S. Food and Drug...

  • IS ANYONE REGULATING? THE CURIOUS STATE OF GMO GOVERNANCE IN THE UNITED STATES. Bratspies, Rebecca M. // Vermont Law Review;Summer2013, Vol. 37 Issue 4, p923 

    The article focuses on governance of genetically modified organisms in the U.S. and analyzes the regulatory system in the U.S. for genetically engineered (GE) crops. It reflects on the existing laws as well as the works of agencies including the U.S. Department of Agriculture and the U.S. Food &...

  • News in brief . . .  // Reactions Weekly;4/3/2004, Issue 995, p2 

    Presents news briefs on drugs labelling rules and research database released in the U.S. as of April 3, 2004. Labelling rules for over the counter drugs released by the Food and Drug Administration effective April 23, 2004; Significance of the Genetic Modification Clinical Research Information...

  • Chapter 9: Genetic Transformation of Chickpea (Cicer arietinum L.) Using Cotyledonary Node Explants. Sanyal, Indraneel; Amla, D. V. // Handbook of New Technologies for Genetic Improvement of Legumes;2007, p147 

    Chapter 9 of the "Handbook of New Technologies for Genetic Improvement of Legumes" is presented. It discusses the use of cotyledonary node explants for the genetic transformation of Chickpea. Chickpea is a pulse crop with protein-rich seeds commonly found in India and Africa, though also grown...

  • Chapter 13: Agrobacterium-Mediated Transformation of Pea (Pisum sativum L.). Nadolska-Orczyk, Anna // Handbook of New Technologies for Genetic Improvement of Legumes;2007, p187 

    Chapter 13 of the "Handbook of New Technologies for Genetic Improvement of Legumes" is presented. This chapter explores the genetic transformation of pea (Pisum sativum L.) through Agrobacterium-mediated methods. Researchers documented a dependence of sensitivity to inoculation with...

  • Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins. Brill-Almon, Einat; Stern, Baruch; Afik, Daniel; Kaye, Joel; Langer, Noga; Bellomo, Stephen; Shavit, Moni; Pearlman, Andrew; Lippin, Yitzhak; Panet, Amos; Shani, Noam // Molecular Therapy;Aug2005, Vol. 12 Issue 2, p274 

    Abstract: Systemic delivery of therapeutic proteins through gene transfer approaches has been carried out mostly by ex vivo transduction of single cells or by direct in vivo injection of an expression vector. In this work an intact miniature biopsy of human dermis (microdermis) is harvested and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics